238 related articles for article (PubMed ID: 34626214)
1. The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment.
Callegaro G; Kunnen SJ; Trairatphisan P; Grosdidier S; Niemeijer M; den Hollander W; Guney E; Piñero Gonzalez J; Furlong L; Webster YW; Saez-Rodriguez J; Sutherland JJ; Mollon J; Stevens JL; van de Water B
Arch Toxicol; 2021 Dec; 95(12):3745-3775. PubMed ID: 34626214
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury.
Copple IM; den Hollander W; Callegaro G; Mutter FE; Maggs JL; Schofield AL; Rainbow L; Fang Y; Sutherland JJ; Ellis EC; Ingelman-Sundberg M; Fenwick SW; Goldring CE; van de Water B; Stevens JL; Park BK
Arch Toxicol; 2019 Feb; 93(2):385-399. PubMed ID: 30426165
[TBL] [Abstract][Full Text] [Related]
3. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
4. Toxicogenomic module associations with pathogenesis: a network-based approach to understanding drug toxicity.
Sutherland JJ; Webster YW; Willy JA; Searfoss GH; Goldstein KM; Irizarry AR; Hall DG; Stevens JL
Pharmacogenomics J; 2018 May; 18(3):377-390. PubMed ID: 28440344
[TBL] [Abstract][Full Text] [Related]
5. Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment.
Kunnen SJ; Arnesdotter E; Willenbockel CT; Vinken M; van de Water B
ALTEX; 2024; 41(2):213-232. PubMed ID: 38376873
[TBL] [Abstract][Full Text] [Related]
6. A network-based transcriptomic landscape of HepG2 cells uncovering causal gene-cytotoxicity interactions underlying drug-induced liver injury.
Wijaya LS; Gabor A; Pot IE; van de Have L; Saez-Rodriguez J; Stevens JL; Le Dévédec SE; Callegaro G; van de Water B
Toxicol Sci; 2024 Feb; 198(1):14-30. PubMed ID: 38015832
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Transcriptional Biomarkers of Xenobiotic Receptor Activation in Rat Liver for the Early Assessment of Drug Safety Liabilities.
Podtelezhnikov AA; Monroe JJ; Aslamkhan AG; Pearson K; Qin C; Tamburino AM; Loboda AP; Glaab WE; Sistare FD; Tanis KQ
Toxicol Sci; 2020 May; 175(1):98-112. PubMed ID: 32119089
[TBL] [Abstract][Full Text] [Related]
8. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans.
Uehara T; Kiyosawa N; Shimizu T; Omura K; Hirode M; Imazawa T; Mizukawa Y; Ono A; Miyagishima T; Nagao T; Urushidani T
Hum Exp Toxicol; 2008 Jan; 27(1):23-35. PubMed ID: 18480146
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Conserved Toxicogenomic Responses in Chemically Exposed Hepatocytes across Species and Platforms.
El-Hachem N; Grossmann P; Blanchet-Cohen A; Bateman AR; Bouchard N; Archambault J; Aerts HJ; Haibe-Kains B
Environ Health Perspect; 2016 Mar; 124(3):313-20. PubMed ID: 26173225
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNFα-mediated hepatotoxicity.
Fredriksson L; Wink S; Herpers B; Benedetti G; Hadi M; de Bont H; Groothuis G; Luijten M; Danen E; de Graauw M; Meerman J; van de Water B
Toxicol Sci; 2014 Jul; 140(1):144-59. PubMed ID: 24752500
[TBL] [Abstract][Full Text] [Related]
11. Parallelogram approach using rat-human in vitro and rat in vivo toxicogenomics predicts acetaminophen-induced hepatotoxicity in humans.
Kienhuis AS; van de Poll MC; Wortelboer H; van Herwijnen M; Gottschalk R; Dejong CH; Boorsma A; Paules RS; Kleinjans JC; Stierum RH; van Delft JH
Toxicol Sci; 2009 Feb; 107(2):544-52. PubMed ID: 19008212
[TBL] [Abstract][Full Text] [Related]
12. Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes.
Jetten MJ; Ruiz-Aracama A; Coonen ML; Claessen SM; van Herwijnen MH; Lommen A; van Delft JH; Peijnenburg AA; Kleinjans JC
Arch Toxicol; 2016 May; 90(5):1103-15. PubMed ID: 26104854
[TBL] [Abstract][Full Text] [Related]
13. Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain.
Jiang J; Briedé JJ; Jennen DG; Van Summeren A; Saritas-Brauers K; Schaart G; Kleinjans JC; de Kok TM
Toxicol Lett; 2015 Apr; 234(2):139-50. PubMed ID: 25704631
[TBL] [Abstract][Full Text] [Related]
14. A novel transcriptomics based in vitro method to compare and predict hepatotoxicity based on mode of action.
De Abrew KN; Overmann GJ; Adams RL; Tiesman JP; Dunavent J; Shan YK; Carr GJ; Daston GP; Naciff JM
Toxicology; 2015 Feb; 328():29-39. PubMed ID: 25475144
[TBL] [Abstract][Full Text] [Related]
15. Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in Collaborative Cross mice.
Mosedale M; Cai Y; Eaddy JS; Kirby PJ; Wolenski FS; Dragan Y; Valdar W
Toxicology; 2021 Sep; 461():152902. PubMed ID: 34418498
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of eIF2α mitigates endoplasmic reticulum stress and hepatocyte necroptosis in acute liver injury.
Tian RD; Chen YQ; He YH; Tang YJ; Chen GM; Yang FW; Li Y; Huang WG; Chen H; Liu X; Lin SD
Ann Hepatol; 2020; 19(1):79-87. PubMed ID: 31548168
[TBL] [Abstract][Full Text] [Related]
17. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
[TBL] [Abstract][Full Text] [Related]
18. Toxicogenomics-based prediction of acetaminophen-induced liver injury using human hepatic cell systems.
Rodrigues RM; Heymans A; De Boe V; Sachinidis A; Chaudhari U; Govaere O; Roskams T; Vanhaecke T; Rogiers V; De Kock J
Toxicol Lett; 2016 Jan; 240(1):50-9. PubMed ID: 26497421
[TBL] [Abstract][Full Text] [Related]
19. Application of the comparison approach to open TG-GATEs: A useful toxicogenomics tool for detecting modes of action in chemical risk assessment.
Heusinkveld HJ; Wackers PFK; Schoonen WG; van der Ven L; Pennings JLA; Luijten M
Food Chem Toxicol; 2018 Nov; 121():115-123. PubMed ID: 30096367
[TBL] [Abstract][Full Text] [Related]
20. Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury?
Holman NS; Mosedale M; Wolf KK; LeCluyse EL; Watkins PB
Toxicol Sci; 2016 Jun; 151(2):365-75. PubMed ID: 26962055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
